This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Oric Pharmaceuticals, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Unveiling the Innovations of Inventor Amit Nayyar
Introduction: Meet Amit Nayyar, a brilliant inventor based in Montreal, CA, who has transformed the field of medicine with his groundbreaking patent on Polo like kinase 4 inhibitors. With a keen focus on developing compounds to combat cancer, Amit Nayyar's work stands at the forefront of innovative pharmaceutical solutions.
Latest Patents: Amit Nayyar holds a remarkable patent for Polo Like Kinase 4 inhibitors - compounds that show promising results in inhibiting PLK4, a protein associated with cancer progression. These compounds, represented by Formula (I), have opened new avenues in cancer treatment by offering potent inhibitory effects.
Career Highlights: Amit Nayyar is associated with Oric Pharmaceuticals, Inc., a leading pharmaceutical company dedicated to developing novel therapies for various diseases. Through his expertise and dedication, Amit has significantly contributed to the advancement of cancer treatment strategies.
Collaborations: Alongside his colleagues Chudi Ndubaku and Jared Moore, Amit Nayyar has fostered a collaborative environment that nurtures innovation and excellence. Together, they have synergized their skills to bring forth pioneering pharmaceutical compositions aimed at revolutionizing cancer therapy.
Conclusion: In conclusion, Amit Nayyar's inventive spirit and scientific acumen have propelled him to the forefront of pharmaceutical innovation. His patent on Polo Like Kinase 4 inhibitors not only showcases his research prowess but also highlights his commitment to combating cancer and improving patients' lives. Amit Nayyar's contributions undoubtedly resonate as a beacon of hope in the realm of medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
